Add-on dupilumab reduces OCS use in patients with steroid-dependent severe asthma | Latest news for Doctors, Nurses and Pharmacists | Respirology - MIMS


8/18/2022 12:00:00 AM2 years 8 months ago
by Audrey Abella

In patients with chronic dependence on oral corticosteroids (OCS) for severe asthma, long-term exposure to dupilumab supports sustained reduction in O...

In patients with chronic dependence on oral corticosteroids (OCS) for severe asthma, long-term exposure to dupilumab supports sustained reduction in OCS dosage and improvement in clinical outcomes f… [+3735 chars]

full article...